Biological and chemical hazards of forensic skeletal analysis

Journal of Forensic Sciences

Volumn 43, Issue 5, 1998, Pages 940-948

  Galloway, Alison ^a   Snodgrass, J Josh ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Florida ^*  (United States)

Author keywords

Forensic anthropology; Forensic science; Hazardous materials; Physical anthropology; Skeletal analysis

Indexed keywords

ANIMAL TISSUE; BLOODBORNE BACTERIUM; EXPOSURE; FORENSIC IDENTIFICATION; HAZARD; HUMAN; HUMAN TISSUE; LABORATORY PERSONNEL; NONHUMAN; PHYSICAL ANTHROPOLOGY; PRIORITY JOURNAL; REVIEW; SKELETON; WASTE DISPOSAL;

EID: 0031658450     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: 10.1520/jfs14338j     Document Type: Review

References (71)

1. 29 Code of Federal Regulations 1910.1030 Occupational Exposure to Bloodborne Pathogens.
2. Li L, Zhang X, Constaninte NT, Smialek, JE. Seroprevalence of parenterally transmitted viruses (HIV-1, HBV, HCV and HTLV-I/II). J Forensic Sci 1993;38:1075-83.
3. Montagnier L, Clavel F. Human immunodeficiency viruses. In Webster RG and Granoff A. editors. Encyclopedia of Virology. San Diego: Academic Press, 1994;674-81.
4. Tardiff K, Marzuk PM, Leon AC, Hirsch CS, Stajic M, Portera L, et al. HIV seroprevalence rates among homicide victims in New York City: 1991-1993. J Forensic Sci 1997;42:1070-3.
5. Koops E, Lieske K, Püschel K, Janssen W. HIV-infection in the autopsy material (Hamburg 1984-1989). Acta Morphol Hung 1992;40:103-11.
6. Nicolosi A. Human immunodeficiency virus (HIV-1): infectivity, transmission, risk behaviours and host susceptibility. Funct Neurol 1992;7:13-29.
7. Penning R, Tutsch-Bauer E, Beer G, Gurller L, Spann W. HIV infection in legal autopsies. Beitr Gerichtl Med 1989;47:23-9.
8. Slade JS, Pike EB, Eglin RP, et al. The survival of human immunodeficiency virus in water, sewage and sea water. Water Sci Technol 1989;21:55-9.
9. Marcus, R, CDC Cooperative Needlestick Surveillance Group. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N Eng J Med 1988;319:1118-23.
10. Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990;133:740-6.
11. Klatt EC, Nogushi TT. The medical examiner and AIDS. Lipshaw Lableader 1989;5:1-2.
12. Centers for Disease Control and Prevention. Office of Health and Safety. Biosafety Branch. Use of bleach in prevention of transmission of HIV in health-care settings. URL address: http: //www.cdc.gov/od/ohs/biosfty/bleachiv.html.
13. Robinson WS. Hepatitis B virus: general features (human). In Webster RG and Granoff A, editors. Encyclopedia of Virology, Academic Press, San Diego, 1994;554-9.
14. Centers for Disease Control. Guidelines for prevention of human immunodeficiency virus and hepatitis B virus to heal care and public safety workers. MMWR Morb Mortal Wkly Rep 1989;38:32-3.
15. Glick M, Muzuyka BC, Garfunkel AA. Viability, transmissibility and risk assessment of HIV. Comp Contin Educ Dentist 1992;13: 374-80.
16. Lai MMC. Hepatitis delta virus. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994;574-80.
17. Purcell RH. Hepatitis C virus. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994; 569-74.
18. Kiyosawa K, Sodeyama T, Tanaka E, Furuta S. Hepatitis C virus infection in health care workers. In Nichioka K, Suzuki H, Mishiro S, Oda T, editors. Viral Hepatitis and Liver Disease: Molecules Today, More Cures Tomorrow. Tokyo: Springer-Verlag. 1994; 479-82.
19. Estaban JI, Gomez J, Martell M, Cabot B, Quer J, Camps J, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-60.
20. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih W-K, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336: 747-54.
21. Lemon SM. Hepatitis A virus. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994;546-54.
22. Bradley DW. Hepatitis E virus. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994;580-6.
23. Clark R. OSHA enforcement policy and procedures for occupational exposure to tuberculosis. Infect Control Hosp Epidemiol 1993;14:694-9.
24. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995;332:92-8.
25. Templeton GL, Illing LA, Young L, Cave D, Stead WW, Bates JH. The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Intern Med 1995;122:922-5.
26. Markowitz SB. Epidemiology of tuberculosis among health care workers. Occup Med 1994;9:589-608.
27. Rowinska-Zakrzewska E, Szopinski J, Remiszewski P, Szymanska D, Miller M, Pawlicka L, et al. Tuberculosis in the autopsy material: Analysis of 1500 autopsies performed between 1972 and 1991 in the Institute of Tuberculosis and Chest Diseases, Warsaw, Poland. Tuber Lung Dis 1995;76:349-54.
28. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Cruetzfeldt-Jakob disease. Nature 1991;352:340-2.
29. Prusiner SB. Neurodegeneration in humans caused by prions. West J Med 1994;161:264-72.
30. Prusiner SB. Prion diseases and the BSE crisis. Science 1997;278: 245-51.
31. Holman RC, Khan AS, Kent J, Strine TW, Schonberger LB. Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology 1995;14:174-81.
32. Martinez-Lage JR, Poza M, Sola J, Tortosa JG, Brown P, Cerrenakova L, et al. Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neurology Neurosurg Psychiatry 1994; 57:1091-4.
33. Maneulidis L, Manuelidis EE. Spongiform encephalopathies: Creutzfeldt-Jakob disease, scrapie and related transmissible encephalopathies. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994; 1361-9.
34. Budka H, Aguzzi A, et al. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:319-22.
35. Gibbs CJ Jr., Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurology Neurosurg Psychiatry 1994;57:757-8.
36. Aurelian L. Herpes simplex viruses: general features. In Webster RG and Granoff A. editors. Encyclopedia of Virology. San Diego: Academic Press, 1994;587-93.
37. Balfour HH, Heussner RC. Herpes diseases and your health. Minneapolis: University of Minnesota. 1984.
38. Whitley RJ. Epidemiology of herpes simplex viruses. In Roizman B, editor. The Herpes Viruses. New York: Plenum Press. 1984;3: 1-44.
39. Dumbell K. Smallpox and monkeypox viruses. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994; 1339-45.
40. Public Health Reports. WHO sets date to destroy smallpox stocks. 1996;111:388.
41. Joklik WK, Moss B, Fields BN, Bishop DHL, Sandakhchiev LS. Why the smallpox virus stocks should not be destroyed. Science 1993;262:1225-6.
42. Downie AW, Dumbell KR. Survival of variola virus in dried exudate and crusts from smallpox patients. Lancet April 26, 1947; 550-3.
43. Zuckerman AJ. Palaeontology of smallpox. Lancet Dec 22/29, 1984:1454.
44. Klenk H-D, Slenczka W, Feldman H. Marburg and Ebola viruses. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994;827-32.
45. Feldman H, Klenk H-D. Marberg and Ebola viruses. Advances in Virus Research, Vol. 47. San Diego: Academic Press. 1996;1-52.
46. Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontaminant laboratory. Lancet 1995;346: 1669-71.
47. McCormick JB. Lassa, Junin, Machupo and Guanarito viruses. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press, 1994;776-86.
48. Nzerue MC. Lassa fever: a review of virology, immunopathogenesis and algorithms for control and therapy. Cent Afr J Med 1992; 38:247-52.
49. Bulmer GS, Fromtling RA. Pathogenic mechanisms of mycotic agents. In Howard DJ, editor. Fungi Pathogenic for Humans and Animals. Part B: Pathogenicity and Detection: I. New York: Marcel Dekkar. 1983;1-59.
50. Hall NK, Larsh HW. Epidemiology of the mycoses. In Howard DH, editor. Fungi Pathogenic for Humans and Animals. Part B: Pathogenicity and Detection: I. New York: Marcel Dekkar. 1989; 195-228.
51. Schaechter M, Medoff G, Eisenstein BI. Mechanisms of Microbial Disease. 2nd Ed. Baltimore: Williams and Wilkins. 1993.
52. Schneider E, Hajjeh RA, Spiegel RA, Jibson RW, Harp EL, Marshall GA, et al. A coccidioidomycosis outbreak following the Northridge. California earthquake. JAMA 1997;277:904-8.
53. Pappagianis D. Marked increase in cases of coccidiodomycosis in California: 1991, 1992. and 1993. Clin Infect Dis 1994;19:S14-8.
54. Anderson JF. Mammalian and avian reservoirs for Borrelia burgdorferi. In Benach JL. Bosler EM. editors. Lyme Disease and Related Disorders. Ann N Y Acad Sci 1988;539:190-1.
55. Spielman A. Prospects for suppressing transmission of Lyme disease. In Benach JL, Bosler EM, editors. Lyme Disease and Related Disorders. Ann N Y Acad Sci 1988;539:212-20.
56. Schmaljohn CS, Dalrymple JM. Hantaviruses. In Webster RG and Granoff A, editors. Encyclopedia of Virology. San Diego: Academic Press. 1994;538-45.
57. Wamer GS. Hantavirus illness in humans: review and update. South Med J 1996;89:264-71.
58. Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis 1996;173:1297-1303.
59. Vitek CR, Breiman RF, Ksiazek TG, Rollin PE, McLaughlin JC, Umland ET, et al. Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis 1996;22: 824-6.
60. Fink TM. Rodents, human remains and North American hantaviruses: risk factors and prevention measures for forensic science personnel - a review. J Forensic Sci 1996;41:1052-6.
61. CA Hazard Evaluation System and Information Service. Understanding Toxic Substances: An Introduction to Chemical Hazards in the Workplace. Berkeley.
62. Snyder RG, Burdi A, Gaul G. A rapid technique for preparation of human fetal and adult skeletal material. J Forensic Sci 1975;20: 576-80.
63. CA Hazard Evaluation System and Information Service. "Formaldehyde" HESIS Fact Sheet No. 6. 1987. Berkeley.
64. CA Office of Administrative Law. Barclays Official California Code of Regulations. Title 8. 1992. South San Francisco: Barclays Law Publications.
65. Paustenbach D, Alarie Y, Kulle T, Schachter N, Smith R, Swenberg J, et al. A recommended occupational exposure limit for formaldehyde based on irritation. J Toxicol Environ Health 1997;50:217-63.
66. Wantke F, Focke M, Hemmer W, Tschabitcher M, Gann M, Tappler P, et al. Formaldehyde and phenol exposure during an anatomy dissection course: a possible source of IgE-mediated sensitization? Allergy 1996;51:837-41.
67. Western J, Locker G. Frequency of glove puncture in the postmortem room. J Clin Pathol 1992;45:177-8.
68. Heese A, Peters K-P, Koch HU, Hornstein OP. Allergy against latex gloves. Allergologie 1995;18:358-65.
69. Suruda A, Wallace D, Moser R. Tuberculosis and the need for respiratory protection for health care workers. West J Med 1994; 160:566-7.
70. Margolis HS. Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond. J Infect Dis 1993;168:9-14.
71. Tilzey AJ. Hepatitis B vaccine boosting: the debate continues. Lancet 1995;345:1000-1.